Effect of treatment with dapagliflozin is consistent across the range of body mass index in patients with HFrEF: an analysis of the DAPA-HF trial

Citation
Jhund PS, Adamson C, Inzucchi SE, et al. Poster 1027-03 presented at ACC.20/WCC Virtual, 28 March 2020.